These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21677358)

  • 1. Glutamate NMDA receptors in pathophysiology and pharmacotherapy of selected nervous system diseases.
    Dobrek L; Thor P
    Postepy Hig Med Dosw (Online); 2011 Jun; 65():338-46. PubMed ID: 21677358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric modulators of NMDA receptors: multiple sites and mechanisms.
    Zhu S; Paoletti P
    Curr Opin Pharmacol; 2015 Feb; 20():14-23. PubMed ID: 25462287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting NMDA Receptors at the Neurovascular Unit: Past and Future Treatments for Central Nervous System Diseases.
    Seillier C; Lesept F; Toutirais O; Potzeha F; Blanc M; Vivien D
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Methyl-D-Aspartate (NMDA)-Type Glutamate Receptors and Demyelinating Disorders: A Neuroimmune Perspective.
    Abhari AP; Etemadifar M; Yazdanpanah N; Rezaei N
    Mini Rev Med Chem; 2022; 22(20):2624-2640. PubMed ID: 35507747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of excitatory amino acids in neuropathology].
    Wikinski SI; Acosta GB
    Medicina (B Aires); 1995; 55(4):355-65. PubMed ID: 8728878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [NMDA-type glutamate receptor and schizophrenia].
    Nishikawa T; Ishiwata S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):217-24. PubMed ID: 25069261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate as a neurotransmitter in the brain: review of physiology and pathology.
    Meldrum BS
    J Nutr; 2000 Apr; 130(4S Suppl):1007S-15S. PubMed ID: 10736372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of glutamate and excitotoxicity in neurologic diseases].
    Hugon J; Vallat JM; Dumas M
    Rev Neurol (Paris); 1996 Apr; 152(4):239-48. PubMed ID: 8763652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate in neurologic diseases.
    Bittigau P; Ikonomidou C
    J Child Neurol; 1997 Nov; 12(8):471-85. PubMed ID: 9430311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature dependence of N-methyl-D-aspartate receptor channels and N-methyl-D-aspartate receptor excitatory postsynaptic currents.
    Korinek M; Sedlacek M; Cais O; Dittert I; Vyklicky L
    Neuroscience; 2010 Feb; 165(3):736-48. PubMed ID: 19883737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological Roles of Non-Neuronal NMDA Receptors.
    Hogan-Cann AD; Anderson CM
    Trends Pharmacol Sci; 2016 Sep; 37(9):750-767. PubMed ID: 27338838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Learning from NMDA receptor trafficking: clues to the development and maturation of glutamatergic synapses.
    Pérez-Otaño I; Ehlers MD
    Neurosignals; 2004; 13(4):175-89. PubMed ID: 15148446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Integrated Approach for Screening and Identification of Positive Allosteric Modulators of N-Methyl-D-Aspartate Receptors.
    Jambrina E; Cerne R; Smith E; Scampavia L; Cuadrado M; Findlay J; Krambis MJ; Wakulchik M; Chase P; Brunavs M; Burris KD; Gallagher P; Spicer TP; Ursu D
    J Biomol Screen; 2016 Jun; 21(5):468-79. PubMed ID: 26838761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the Role of Glutamate in Presynaptic Development: Possible Contributions of Presynaptic NMDA Receptors.
    Fedder KN; Sabo SL
    Biomolecules; 2015 Dec; 5(4):3448-66. PubMed ID: 26694480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomy and physiology of glutamate in the CNS.
    Greenamyre JT; Porter RH
    Neurology; 1994 Nov; 44(11 Suppl 8):S7-13. PubMed ID: 7526272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms regulating spill-over of synaptic glutamate to extrasynaptic NMDA receptors in mouse substantia nigra dopaminergic neurons.
    Wild AR; Bollands M; Morris PG; Jones S
    Eur J Neurosci; 2015 Nov; 42(9):2633-43. PubMed ID: 26370007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
    Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate-Gated NMDA Receptors: Insights into the Function and Signaling in the Kidney.
    Valdivielso JM; Eritja À; Caus M; Bozic M
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32679780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.